Commonwealth Equity Services’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.2K Buy
+18,451
New +$33K ﹤0.01% 4322
2026
Q1
Sell
-15,102
Closed -$17.1K 4308
2025
Q4
$17.1K Sell
15,102
-5,470
-27% -$8.28K ﹤0.01% 4250
2025
Q3
$38K Buy
20,572
+1,280
+7% +$1.11K ﹤0.01% 4180
2025
Q2
$8K Sell
19,292
-134,485
-87% -$67.9K ﹤0.01% 4235
2025
Q1
$96K Buy
153,777
+136,868
+809% +$164K ﹤0.01% 3998
2024
Q4
$28K Buy
16,909
+1,069
+7% +$1.64K ﹤0.01% 4021
2024
Q3
$29K Buy
+15,840
New +$58.9K ﹤0.01% 3978

Other funds holding ALXO

Commonwealth Equity Services's ALXO Position: Q2 2026 in Review

Commonwealth Equity Services opened a new position in ALX Oncology (ALXO) in Q2 2026: 18,451 shares worth $38.2K. The stake represents ﹤0.01% of the portfolio and ranks #4322 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in ALXO as recently as Q4 2025.

Commonwealth Equity Services first reported a position in ALXO in Q3 2024 and has held it in 7 quarters since. The position peaked at $96K in Q1 2025. 10 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Commonwealth Equity Services held 18,451 shares of ALX Oncology worth $38.2K as of Q2 2026.
  • ALX Oncology was a new Commonwealth Equity Services position in Q2 2026.
  • ALX Oncology made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4322 holding.
  • Commonwealth Equity Services first reported a position in ALX Oncology in Q3 2024 and has held it in 7 quarters since.
  • Commonwealth Equity Services's ALX Oncology position peaked at $96K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.